Logotype for Colt CZ Group SE

Colt CZ Group (CZG) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Colt CZ Group SE

Q2 2024 earnings summary

13 Jun, 2025

Executive summary

  • Achieved record H1 2024 revenues of CZK 9,690m (up 41.2% y-o-y) and adjusted EBITDA of CZK 1,981m (up 35.3% y-o-y), driven by Sellier & Bellot acquisition and US market recovery.

  • Sellier & Bellot acquisition completed in May 2024 for USD 703m, expanding the product portfolio and group scale.

  • Adjusted net profit declined 15.3% y-o-y to CZK 1,015m, mainly due to financial results and one-off adjustments.

  • Results exceeded half-year guidance, with strong Q2 performance and new contracts, including technology transfer to Ukraine.

  • Board of Directors strengthened with appointment of Radek Musil to represent the ammunition segment.

Financial highlights

  • Revenues increased 41.2% y-o-y to CZK 9,690m; adjusted EBITDA rose 35.3% to CZK 1,981m, both exceeding guidance.

  • Adjusted EPS was CZK 25 (down 28.4% y-o-y), impacted by share issuance and S&B acquisition effects.

  • Profit before tax fell 41.2% to CZK 794.8m; net profit dropped 41.7% to CZK 609.6m due to acquisition costs and higher depreciation.

  • Q2 2024 was the strongest quarter in company history, with units sold up 2.8% y-o-y and organic firearms revenue up 26.6%.

  • Total assets increased 79.8% to CZK 46.7bn; net financial debt rose to CZK 15.6bn (net leverage ratio 3.16x).

Outlook and guidance

  • FY 2024 guidance confirmed: revenues CZK 20,000–22,000m post-S&B consolidation, up to CZK 25bn pro-forma; adjusted EBITDA expected at CZK 3,300–3,800m, up to CZK 5.6bn pro-forma.

  • High quarterly seasonality anticipated in H2 2024, with Q4 expected to outperform Q3.

  • Capital expenditures for 2024 expected at CZK 1–1.2bn (approx. 5% of expected revenues).

  • Outlook subject to global demand, inflation, FX rates, and S&B integration.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more